AVITA Medical, Inc. (RCEL) Tops Q3 EPS by 10c

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q3 EPS of ($0.34), $0.10 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $13.4 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM
• AeroVironment restates quarterly financials, citing $89M goodwill error